GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $87,110 | -3.6% | 204,245 | +13.0% | 0.00% | – |
| Q4 2022 | $90,362 | +53.2% | 180,724 | -4.7% | 0.00% | – |
| Q3 2022 | $59,000 | -53.5% | 189,620 | -3.1% | 0.00% | – |
| Q2 2022 | $127,000 | -51.7% | 195,699 | +18.4% | 0.00% | – |
| Q1 2022 | $263,000 | -10.2% | 165,300 | +2.8% | 0.00% | – |
| Q4 2021 | $293,000 | -36.2% | 160,800 | -2.2% | 0.00% | – |
| Q3 2021 | $459,000 | -18.0% | 164,500 | -10.7% | 0.00% | – |
| Q2 2021 | $560,000 | -11.9% | 184,200 | -0.7% | 0.00% | – |
| Q1 2021 | $636,000 | +25.9% | 185,552 | +14.3% | 0.00% | – |
| Q4 2020 | $505,000 | +10.0% | 162,352 | +24.7% | 0.00% | – |
| Q3 2020 | $459,000 | -13.4% | 130,165 | +17.6% | 0.00% | – |
| Q2 2020 | $530,000 | +97.0% | 110,703 | +42.7% | 0.00% | – |
| Q1 2020 | $269,000 | -25.3% | 77,552 | +24.6% | 0.00% | – |
| Q4 2019 | $360,000 | +361.5% | 62,230 | +284.4% | 0.00% | – |
| Q3 2019 | $78,000 | -28.4% | 16,187 | +9.5% | 0.00% | – |
| Q2 2019 | $109,000 | +109.6% | 14,783 | +132.1% | 0.00% | – |
| Q1 2019 | $52,000 | -55.6% | 6,369 | -62.6% | 0.00% | – |
| Q4 2018 | $117,000 | -93.4% | 17,023 | -87.0% | 0.00% | – |
| Q3 2018 | $1,783,000 | -33.6% | 131,320 | -41.8% | 0.00% | -100.0% |
| Q2 2018 | $2,685,000 | +137.2% | 225,545 | +11.1% | 0.00% | – |
| Q1 2018 | $1,132,000 | -26.1% | 203,100 | +21.4% | 0.00% | – |
| Q4 2017 | $1,532,000 | +38.0% | 167,300 | +37.8% | 0.00% | – |
| Q3 2017 | $1,110,000 | +86.2% | 121,400 | +26.4% | 0.00% | – |
| Q2 2017 | $596,000 | +8.8% | 96,027 | -14.4% | 0.00% | – |
| Q1 2017 | $548,000 | +86.4% | 112,206 | +34.4% | 0.00% | – |
| Q4 2016 | $294,000 | +583.7% | 83,466 | +779.9% | 0.00% | – |
| Q3 2016 | $43,000 | +95.5% | 9,486 | +95.5% | 0.00% | – |
| Q2 2016 | $22,000 | -8.3% | 4,851 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -50.0% | 4,851 | -23.6% | 0.00% | – |
| Q4 2015 | $48,000 | -4.0% | 6,351 | -5.4% | 0.00% | – |
| Q3 2015 | $50,000 | -25.4% | 6,715 | 0.0% | 0.00% | – |
| Q2 2015 | $67,000 | +19.6% | 6,715 | +14.1% | 0.00% | – |
| Q1 2015 | $56,000 | -60.0% | 5,886 | -75.6% | 0.00% | – |
| Q4 2014 | $140,000 | +16.7% | 24,100 | +71.3% | 0.00% | – |
| Q3 2014 | $120,000 | +275.0% | 14,067 | +326.3% | 0.00% | – |
| Q2 2014 | $32,000 | -15.8% | 3,300 | -0.5% | 0.00% | – |
| Q1 2014 | $38,000 | – | 3,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|